Protocol No: GM-IMAB-001-03 (the “Protocol”)Monitoring Agreement • December 15th, 2017
Contract Type FiledDecember 15th, 2017This Agreement (the "Monitoring Agreement") is effective as of ● (the “Effective Date”) and is entered into by and between Astellas Pharma Global Development, Inc. located at One Astellas Way, 60062, Illinois, United States of America (“Sponsor”), acting through its authorized representative, PAREXEL International (IRL) Limited, located at 70 Sir John Rogersonś Quay, Dublin 2, Ireland (“CRO”), and Nemocnice Znojmo p.o., located at MUDr.Jana Janskeho 11 ,669 02 Znojmo,Czech Republic, Company No.: 00092584, Tax ID No.: CZ00092584, Represented by: MUDr. Miroslav Kavka, MBA (“Institution”). Sponsor, CRO and Institution are individually referred to as a “Party” and are collectively known as the “Parties”.